Chris Degnan sold $81K of UroGen Pharma stock
By AlphaYouPublished Form 4
Degnan Chris
Reporting filer
Chris Degnan reported selling 2,202 shares of UroGen Pharma Ltd. for about $81K ($36.69 a share on average). Form 4 filed Oct 9, 2026 lists 3 entries.
See the price move since this trade →
- Disclosed
- Oct 9, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Degnan Chris | 2026-10-08 | M | Exercise or conversion | 4483 | Not stated (see footnotes) | 6,763 | 1 day | Filed terms
|
| Ordinary Shares | Degnan Chris | 2026-10-08 | S | Sale | 2202 | 36.69 | 4,561 | 1 day | Filed terms
|
| Restricted Stock Units (derivative) | Degnan Chris | 2026-10-08 | M | Exercise or conversion | 4483 | 0 | 4,484 | 1 day | Filed terms
|
Ordinary Shares
- Owner
- Degnan Chris
- Date
- 2026-10-08
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 4483
- Price
- Not stated (see footnotes)
- Following holdings
- 6,763
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Ordinary Shares
- transaction Date: 2026-10-08
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 4483
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 6763
- direct Or Indirect Ownership: D
Ordinary Shares
- Owner
- Degnan Chris
- Date
- 2026-10-08
- Code
- S
- Action
- Sale
- Quantity
- 2202
- Price
- 36.69
- Following holdings
- 4,561
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Ordinary Shares
- transaction Date: 2026-10-08
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 2202
- id: F2
- transaction Price Per Share: 36.69
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 4561
- direct Or Indirect Ownership: D
Restricted Stock Units (derivative)
- Owner
- Degnan Chris
- Date
- 2026-10-08
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 4483
- Price
- 0
- Following holdings
- 4,484
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Restricted Stock Units
- id: F1
- transaction Date: 2026-10-08
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 4483
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F3
- id: F3
- underlying Security Title: Ordinary Shares
- underlying Security Shares: 4483
- shares Owned Following Transaction: 4484
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Degnan Chris: Chief Financial Officer.
- F1: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- F2: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
- F3: The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025.
Original sources
Prepared automatically from public filing data. Report a correction.